CLDX NASDAQ
Celldex Therapeutics, Inc.
1W: -5.8%
1M: -10.6%
3M: +32.8%
YTD: +13.2%
1Y: +49.2%
3Y: -8.0%
5Y: +12.9%
$30.73
+0.15 (+0.49%)
Weekly Expected Move ±4.9%
$28
$30
$31
$33
$34
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1M
Revenue
-89.2% YoY
$-284M
Net Income
-58.6% YoY
$-226M
Free Cash Flow
-31.2% YoY
-5593.3%
Gross Margin
-562900.0%
Op. Margin
-524566.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-44.5%
ROA-41.3%
ROIC-2234.5%
Valuation
P/E-7.2
P/B4.5
EV/EBITDA-5.3
Leverage
Debt/Equity0.00
Current Ratio10.49
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z17.62
Beneish M109.22